NEW YORK, Jan. 23-Decode will pair its Clinical Genome Miner tool with IBM's hardware and software in a joint marketing and sales agreement, the two companies said today.
Under a three-year agreement, the two companies will partner to market and sell the combined system, and will cooperatively provide consulting, implementation and integration services.
IBM's contribution will include its eServer pSeries running AIX and its xSeries running Linux. It will also supply its WebSphere infrastructure software and its DB2 database software. The system will make use of DiscoveryLink data integration methods.
Through the agreement, IBM becomes Decode's preferred IT provider.
Decode's CGM system can be used to isolate and identify gene and gene variations, and associate these with diseases.